Fibromodulin formulation for reducing corneal scarring
Abstract:
A formulation for reducing corneal scarring and related eye conditions, is disclosed. The formulation comprises an effective amount of fibromodulin and can be administered intraocularly, such as by topical application, injection into the eye, or implantation in or on the eye.
Public/Granted literature
Information query
Patent Agency Ranking
0/0